LataMed AI Corp. partners with Venezuelan pharmacies to deploy AI-powered prescription processing and fulfillment platform, aiming to modernize healthcare logisticsLataMed AI Corp. partners with Venezuelan pharmacies to deploy AI-powered prescription processing and fulfillment platform, aiming to modernize healthcare logistics

LataMed AI Partners With Venezuelan Pharmacies for AI-Powered Prescription Fulfillment

2026/05/26 20:53
3분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 [email protected]으로 연락주시기 바랍니다

LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that it has reached commercial terms with two leading pharmacy retail operators in Caracas, Venezuela, to deploy its AI-powered prescription processing and pharmaceutical fulfillment platform. The initiative is a key step in the company’s broader Latin American commercialization strategy and aims to establish an operational framework for its AI-driven healthcare logistics ecosystem.

Venezuela was selected as the initial target market due to increasing interest in technology-enabled healthcare infrastructure and opportunities for modernization within the country’s pharmaceutical distribution sector. Management believes that successful deployment and market evaluation in Venezuela could provide a model for expansion into other South American markets as part of the company’s long-term regional strategy.

The platform is designed to streamline traditional prescription fulfillment workflows through mobile-enabled prescription intake, artificial intelligence-based text recognition, automated inventory verification, fulfillment coordination, and delivery routing technologies. According to the company, the platform addresses operational inefficiencies in underserved healthcare distribution markets across Latin America.

Under the planned deployment, the platform is intended to improve prescription processing efficiency, reduce administrative overhead, optimize pharmacy inventory coordination, and enhance customer accessibility through technology-enabled fulfillment and delivery systems. Management believes the initiative offers several commercial advantages, including initial entry into an active pharmaceutical retail environment in a major Latin American metropolitan market, real-world evaluation opportunities for the platform, potential recurring transaction-based revenue from prescription fulfillment volumes, and a scalable framework for future regional expansion.

The pharmacy fulfillment initiative is intended to integrate with LataMed’s broader digital healthcare ecosystem, which includes telehealth applications, healthcare analytics infrastructure, patient engagement technologies, and AI-assisted healthcare coordination platforms currently under development. Management believes that integrating pharmacy fulfillment capabilities will enhance operational scalability, improve user accessibility, support future platform interoperability, and strengthen the company’s long-term digital healthcare commercialization strategy throughout Latin America.

Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: ‘We believe pharmacy fulfillment represents a natural extension of our digital healthcare infrastructure strategy. By combining AI-enabled prescription processing, logistics coordination, and pharmacy retail participation, we are continuing development of healthcare technology solutions designed to support accessibility, operational efficiency, and scalability across Latin America.’

The company emphasized that the platform and related deployment activities remain subject to continued operational planning, technology integration, commercial readiness, regulatory considerations, partner implementation timelines, financing availability, and market adoption. No assurance can be provided regarding the timing of broader commercial deployment, transaction volumes, revenue generation, geographic expansion, or operational success.

LataMed continues to advance telehealth deployment initiatives, healthcare analytics integration, operational scalability planning, strategic relationship development, and broader commercialization efforts associated with its long-term digital healthcare ecosystem strategy throughout Latin America and other emerging markets.

For more information, visit LataMed AI’s website or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is LataMed AI Partners With Venezuelan Pharmacies for AI-Powered Prescription Fulfillment.

The post LataMed AI Partners With Venezuelan Pharmacies for AI-Powered Prescription Fulfillment appeared first on citybuzz.

시장 기회
Gensyn 로고
Gensyn 가격(AI)
$0.02992
$0.02992$0.02992
+0.33%
USD
Gensyn (AI) 실시간 가격 차트

AI Strategy: Powered 24/7

AI Strategy: Powered 24/7AI Strategy: Powered 24/7

Generate automated strategies using natural language

면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, [email protected]으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

No Chart Skills? Still Profit

No Chart Skills? Still ProfitNo Chart Skills? Still Profit

Copy top traders in 3s with auto trading!